Ogilvy Healthworld's Diane Iler-Smith to Judge the 2014 CLIO Healthcare Awards

Marketwired

PARSIPPANY, NJ--(Marketwired - Jul 25, 2014) - Ogilvy CommonHealth Worldwide (www.ochww.com), the health behavior experts of Ogilvy & Mather (www.ogilvy.com), today announced Diane Iler-Smith, executive vice president, chief creative officer at Ogilvy Healthworld in New York, NY, has been selected as a juror for the 2014 CLIO Healthcare Awards.

Ogilvy CommonHealth Worldwide is a WPP company (NASDAQ: WPPGY) (www.wpp.com). The organization houses and maintains individual Ogilvy CommonHealth and Ogilvy Healthworld brand identities within the marketplace.

The CLIO Healthcare Awards, now in its sixth year, is an extension of the CLIO Awards, one of the world's most recognized and respected awards competitions for advertising, design and communication. Ms. Iler-Smith, along with 16 other global leaders in the healthcare communications industry, will be on the jury for film, innovative media, integrated campaign, and audio. The CLIO Awards and CLIO Healthcare Awards are produced by Prometheus Global Media, a diversified company with leading assets in the media and entertainment arenas. For more information about the CLIO Healthcare Awards, go to www.cliohealthcare.com.

Ogilvy CommonHealth Worldwide is committed to creativity and effectiveness in healthcare communications, everywhere. With 56 offices across 32 markets, the group provides marketing services including brand identity and development, clinical trial recruitment, digital/interactive services, direct-to-consumer, direct-to-patient, global integration, managed care marketing, market research and analytics, media planning and buying, medical advertising and promotion, medical education, public affairs and relations, relationship marketing, and strategic consulting. The network also offers scientific communications and publications services through a wholly owned separate legal entity.

Contact:

Beth Paulino
Kerianne Slattery
Ogilvy CommonHealth Worldwide
973.352.1000 tel
View Comments (0)